Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
JobWatch
White Papers
Patient Education
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» White House Considering Minority Candidates for FDA Commissioner
Looking to read the full article? Subscribe today!
White House Considering Minority Candidates for FDA Commissioner
May 4, 2021
The White House has reportedly broadened its potential picks for permanent FDA commissioner to include several minority women.
Upcoming Events
17
Jun
Accelerate the Startup of Your Clinical Trials Without Sacrificing Quality: Common Pitfalls that Cause Delays and How to Avoid Them
13
Jul
Decentralized Clinical Trials: Benefits of a Better Patient Experience
Featured Products
Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Featured Stories
FDA Has Long Way to Go to Correct Trial Reporting Noncompliance, Study Shows
Selective Use of Decentralization Methods Best Bet for Most Trials Postpandemic
Stop Over-Reporting Adverse Events, FDA Officials Tell Sponsors
Ask the Experts: FDA Advice on Protocol Deviations
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
